首页> 外国专利> REGENERATING FUNCTIONAL NEURONS FOR TREATMENT OF NEURAL INJURY CAUSED BY DISRUPTION OF BLOOD FLOW

REGENERATING FUNCTIONAL NEURONS FOR TREATMENT OF NEURAL INJURY CAUSED BY DISRUPTION OF BLOOD FLOW

机译:再生功能神经元治疗因血液流动紊乱而引起的神经损伤

摘要

Methods of treating the effects of disruption of normal blood flow in the CNS in an individual subject in need thereof are provided according to aspects of the present invention which include administering a therapeutically effective dose of exogenous NeuroD1 to an area where normal blood flow has been disrupted. Compositions are provided including 1) a recombinant adeno-associated adenovirus expression vector comprising a glial cell specific promoter operably linked to a nucleic acid encoding a site-specific recombinase and 2) a recombinant adeno-associated adenovirus expression vector comprising a ubiquitous promoter operably linked to a nucleic acid encoding NeuroD1, wherein the nucleic acid encoding NeuroD1 is inverted and flanked by two sets of site-specific recombinase recognition sites such that action of the recombinase irreversibly inverts the nucleic acid encoding NeuroD1 such that NeuroD1 is expressed in a mammalian cell.
机译:根据本发明的方面,提供了在有需要的个体受试者中治疗CNS中正常血流中断的作用的方法,该方法包括向正常血流中断的区域施用治疗有效剂量的外源NeuroD1。 。提供的组合物包括:1)包含与编码位点特异性重组酶的核酸可操作地连接的神经胶质细胞特异性启动子的重组腺相关的腺病毒表达载体,和2)包含与以下基因可操作地连接的遍在启动子的重组腺相关的腺病毒表达载体编码NeuroD1的核酸,其中编码NeuroD1的核酸被两个位点特异性重组酶识别位点颠倒并侧翼,使得重组酶的作用不可逆地反转编码NeuroD1的核酸,从而使NeuroD1在哺乳动物细胞中表达。

著录项

  • 公开/公告号EP3589307A4

    专利类型

  • 公开/公告日2020-01-22

    原文格式PDF

  • 申请/专利权人 THE PENN STATE RESEARCH FOUNDATION;

    申请/专利号EP20180760296

  • 发明设计人 CHEN GONG;

    申请日2018-02-28

  • 分类号C12N15/86;A61K48;A61K38;C07K14/47;

  • 国家 EP

  • 入库时间 2022-08-21 11:39:55

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号